Pulmonary Function and Gender in Patients With Persistent Asthma Treated With Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI)

被引：0

作者：

O'Brien, C. D. ^{[1
]}

Uryniak, T. ^{[1
]}

Zangrilli, J. ^{[1
]}

机构：

[1] AstraZeneca LP, Wilmington, DE USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2010年 / 125卷 / 02期

关键词：

D O I：

10.1016/j.jaci.2009.12.267

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：AB68 / AB68

页数：1

共 50 条

[21] Treatment with budesonide/formoterol pressurized metered-dose inhaler in patients with asthma: a focus on patient-reported outcomes
O'Connor, Richard D.
PATIENT-RELATED OUTCOME MEASURES, 2011, 2 : 41 - 55
[22] Safety of budesonide (BUD) and formoterol (FM) in one pressurized metered-dose inhaler (BUD/FM pMDI) in adults and adolescents with mild to moderate persistent asthma.
Korenblat, P. E.
Corren, J.
Miller, C. J.
O'Brien, C. D.
Mezzanotte, W. S.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 98 (01) : A57 - A57
[23] Measured onset of bronchodilation with budesonide and formoterol administered via one pressurized metered-dose inhaler (pMDI) in patients with asthma previously receiving inhaled corticosteroids
Kaiser, H. B.
Miller, C. J.
O'Dowd, L.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S249 - S249
[24] Early bronchodilatory effects of Budesonide/Formoterol pressurized metered-dose inhaler (pMDI) compared with fluticasone Propionate/Salmeterol dry powder inhaler (DPI) and albuterol pMDI in adults with asthma
Hampel, F. C., Jr.
Martin, P.
Mezzanotte, W. S.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S220 - S221
[25] The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counter
Shah, Shailen
White, Martha
Uryniak, Tom
O'Brien, Christopher D.
ALLERGY AND ASTHMA PROCEEDINGS, 2010, 31 (01) : 40 - 48
[26] Effect of budesonide and formoterol administered via one pressurized metered-dose inhaler on lung function in adults and adolescents with moderate to severe persistent asthma
Noonan, M. J.
Rosenwasser, L. J.
Martin, P.
O'Brien, C. D.
O'Dowd, L.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S2 - S2
[27] Long-term safety and systemic effects of budesonide and formoterol administered via one pressurized metered-dose inhaler (pMDI) in children with asthma
Leflein, J. G.
Berger, W. E.
Uryniak, T.
Vervaet, P.
O'Dowd, L.
O'Brien, C. D.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S155 - S155
[28] Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI) on Symptoms of Chronic Obstructive Pulmonary Disease (COPD) in Patients with Moderate to Very Severe COPD
Tashkin, D. P.
Rennard, S. I.
Ramachandran, S.
Martin, P.
Goldman, M.
Martin, U. J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[29] Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids
Kaiser, Harold
Parasuraman, Bhash
Boggs, Robert
Miller, Christopher J.
Leidy, Nancy Kline
O'Dowd, Liza
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 101 (03) : 295 - +
[30] Budesonide/formoterol pressurized metered-dose inhaler: a guide to its use in chronic obstructive pulmonary disease
Drugs & Therapy Perspectives, 2010, 26 (11) : 6 - 9

← 1 2 3 4 5 →